Mental Health Engagement Network (MHEN) (MHEN)

This study has been completed.
Sponsor:
Collaborators:
London Health Sciences Centre
Canadian Mental Health Association
St. Joseph's Health Care London
Information provided by (Responsible Party):
Cheryl Forchuk, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT01473550
First received: November 14, 2011
Last updated: March 4, 2016
Last verified: March 2016

November 14, 2011
March 4, 2016
November 2011
June 2014   (final data collection date for primary outcome measure)
Lehman Quality of Life - Brief Version [ Time Frame: Every 6 months for total of 18 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01473550 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Mental Health Engagement Network (MHEN)
Mental Health Engagement Network (MHEN): Connecting Clients With Their Health Team
Patients with mood disorder or psychotic disorder will be given handheld devices with personal health records to educate, monitor and deliver customizable healthcare tools based on their personal needs. The use of technology has great potential to deliver care more effectively and efficiently. No actual information is on the handheld device - it is accessed from a secure site behind hospital firewalls.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Health Services Research
  • Mood Disorder
  • Psychotic Disorder
Behavioral: Access to TELUS Health Space and Smart Phone
Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.
  • Experimental: Early Intervention
    At Phase 1 (first 3 months of project), the 200 participants in Group 1 will be provided with a Personal Health Record (PHR) through TELUS Health Space, as well as they will be introduced to smart phone technology to ready them for deployment of the prompts and reminders. Two months later, they will be provided with a smart phone.
    Intervention: Behavioral: Access to TELUS Health Space and Smart Phone
  • Experimental: Later Intervention
    A delayed implementation plan will be used (but will have no effect on the standard of care for the remaining 200 participants), so the remaining 200 participants in Group 2 will initially act as a control group, but at Phase 2 (six months later - approximately June 2012) the remaining 200 participants will be introduced to the technology in the same order (PHR -> Smart Phone). Group 2 will have the benefit of any enhancements made during Phase 1 of the project.
    Intervention: Behavioral: Access to TELUS Health Space and Smart Phone
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
400
June 2014
June 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Must be diagnosed with mood disorder or psychotic disorder for a minimum one year
  • Able to make informed consent to participate in the study
  • Able to understand and speak English to the degree necessary to participate in interviews/focus groups

Exclusion Criteria:

  • Younger than 18 or older than 80
Both
18 Years to 80 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT01473550
18451
No
Not Provided
Not Provided
Cheryl Forchuk, Lawson Health Research Institute
Lawson Health Research Institute
  • London Health Sciences Centre
  • Canadian Mental Health Association
  • St. Joseph's Health Care London
Principal Investigator: Cheryl Forchuk, PhD Lawson Health Research Institute; University of Western Ontario
Lawson Health Research Institute
March 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP